Several factors support the theoretical viability of oral BPC-157, though human outcomes remain unproven: Gastric Stability: BPC-157 was originally studied for gastric protection in animal models, meaning the compound was administered directly into the stomach in research settings
10 These modifications aim to reduce metabolic risk factors and promote weight loss, decreasing fat accumulation in the liver by creating a negative energy balance and promoting lipolysis, ultimately reducing fibrosis
Verified Patient Laurie from California Dr
The days of fill out a form, get a prescription are over
A Dentistry.One Oral Health Coach can give you a personalized plan for protecting your teeth, gums, and metabolic health throughout treatment
The page is educational and navigational